// App-Quantinova.ai

: Evaluating the Potential of Harnessing Anti-Leukemia T cells for Treating T-ALL

Researchers

Presenter

  • Todd A Triplett

Principal Investigators

  • Joshua Rios

  • Srividya Kottapalli

  • Andrew D Weinberg

  • Alexander Somma

  • Trevor Sandoval

Medical Centers

  • The University of Texas, Houston, TX

  • LIVESTRONG Cancer Institutes, The University of Texas at Austin Dell Medical School

  • Providence Cancer Ctr., Earle A. Chiles Res. Inst.

  • St. Edward’s University

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

  • Cluster of differentiation 8A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved